EP2650381

Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    31.7.2008
  • :
    21.9.2016
  • :
    13167177.8
  • :
    30.7.2028
  • :
    Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function

31.7.2008
21.9.2016
  • :
    Accera, Inc.
  • :
    380 Interlocken Crescent, Suite 780, 80021, Broomfield, Colorado, US
  • :
    Henderson, Samuel T.
  • :
    Golden, CO, US
  • :
    953074 P
  • :
    31.7.2007
  • :
    US
  • :
    C12Q 1/68, A61K 31/23, A61K 31/7004